Cantor Fitzgerald’s Thermo Fisher Scientific TMO Stock Holding History

Cantor Fitzgerald’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,000	Closed	-$520K	–	391
2024 Q4	$520K	Buy	+1,000	New	+$550K	0.01%	120
2022 Q4	–	Sell	-22,863	Closed	-$11.6M	–	765
2022 Q3	$11.6M	Sell	22,863 -3,697	-14%	-$2.07M	0.25%	125
2022 Q2	$14.4M	Buy	+26,560	New	+$14.6M	0.28%	114

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Cantor Fitzgerald's TMO Position: Q1 2025 in Review

Cantor Fitzgerald sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 1,000 shares — an estimated $520K sold.

Cantor Fitzgerald first reported a position in TMO in Q2 2022 and held it in 3 quarters. The position peaked at $14.4M in Q2 2022. 2,578 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

Cantor Fitzgerald reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
Cantor Fitzgerald sold 1,000 Thermo Fisher Scientific shares in Q1 2025, an estimated $520K.
Cantor Fitzgerald first reported a position in Thermo Fisher Scientific in Q2 2022 and held it in 3 quarters.
Cantor Fitzgerald's Thermo Fisher Scientific position peaked at $14.4M in Q2 2022.
2,578 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Cantor Fitzgerald's 13F filing for Q1 2025, filed 15 May 2025.